HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maria Paris Selected Research

apremilast

6/2022Efficacy and Safety of Apremilast in the Treatment of Patients with Mild-to-Moderate Psoriasis in Japan: Results from PROMINENT, A Phase 3b, Open-Label, Single-Arm Study.
2/2022Apremilast in a Japanese subgroup with Behçet's syndrome: Results from a Phase 3, randomised, double-blind, placebo-controlled study.
1/2022Apremilast monotherapy for long-term treatment of active psoriatic arthritis in DMARD-naïve patients.
1/2022Efficacy and safety of apremilast in patients with mild-to-moderate plaque psoriasis: Results of a phase 3, multicenter, randomized, double-blind, placebo-controlled trial.
1/2022Impact of apremilast on quality of life in Behçet's syndrome: analysis of the phase 3 RELIEF study.
10/2021Nonclinical genotoxicity and carcinogenicity profile of apremilast, an oral selective inhibitor of PDE4.
9/2021Apremilast for oral ulcers associated with active Behçet's syndrome over 68 weeks: long-term results from a phase 3 randomised clinical trial.
2/2021Characteristics of Patients with Psoriasis Treated with Apremilast in the Corrona Psoriasis Registry.
8/2020Long-Term Safety and Tolerability of Apremilast Versus Placebo in Psoriatic Arthritis: A Pooled Safety Analysis of Three Phase III, Randomized, Controlled Trials.
7/2020Efficacy and safety of apremilast in patients with moderate to severe plaque psoriasis of the scalp: Results of a phase 3b, multicenter, randomized, placebo-controlled, double-blind study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maria Paris Research Topics

Disease

9Psoriasis (Pustulosis Palmaris et Plantaris)
06/2022 - 12/2015
8Psoriatic Arthritis
01/2022 - 12/2015
5Oral Ulcer (Mouth Ulcer)
02/2022 - 11/2019
5Headache (Headaches)
01/2022 - 11/2019
5Nausea
01/2022 - 11/2019
4Diarrhea
01/2022 - 11/2019
3Respiratory Tract Infections (Respiratory Tract Infection)
01/2022 - 08/2020
2Pain (Aches)
01/2022 - 09/2021
2Nasopharyngitis
01/2022 - 08/2020
2Neoplasms (Cancer)
10/2021 - 08/2016
1Ankylosing Spondylitis
01/2022
1Obesity
02/2021
1Hyperlipidemias (Hyperlipidemia)
02/2021
1Hypertension (High Blood Pressure)
02/2021
1Vomiting
07/2020
1Herpes Zoster
01/2020
1Tuberculosis (Tuberculoses)
01/2020
1Hepatitis C
01/2020
1Infections
08/2016
1Skin Neoplasms (Skin Cancer)
08/2016
1Cardiovascular Diseases (Cardiovascular Disease)
12/2015
1Persistent Infection
03/2006
1Reinfection
03/2006
1Otitis Media
03/2006

Drug/Important Bio-Agent (IBA)

15apremilastIBA
06/2022 - 07/2018
2Antirheumatic Agents (DMARD)IBA
01/2022 - 07/2018
2Biological ProductsIBA
02/2021 - 11/2019
1Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
10/2021
1Phosphodiesterase 4 InhibitorsIBA
02/2020
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020
1insulin receptor-related receptor (IRR)IBA
08/2016
1omega-Chloroacetophenone (Mace)IBA
12/2015
1Penicillins (Penicillin)FDA Link
03/2006
1SuspensionsIBA
03/2006
1Cefdinir (Omnicef)FDA LinkGeneric
03/2006

Therapy/Procedure

3Therapeutics
06/2022 - 07/2020